# Dexamethasone for ESPB in Total Hip Arthroplasty

> **NCT06789042** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Hip Osteoarthritis
- Hip Arthropathy
- Hip Arthritis

## Interventions

- **DRUG:** 0.9%NaCl
- **DRUG:** Dexamethasone 4mg

## Key facts

- **NCT ID:** NCT06789042
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-01
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-07-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06789042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06789042, "Dexamethasone for ESPB in Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06789042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*